Physical and functional interaction between p53 and the Werner's syndrome protein

被引:138
作者
Blander, G
Kipnis, J
Leal, JFM
Yu, CE
Schellenberg, GD
Oren, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] Vet Affairs Med Ctr, Seattle, WA 98108 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
关键词
D O I
10.1074/jbc.274.41.29463
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Werner's syndrome is a human autosomal recessive disorder leading to premature aging. The mutations responsible for this disorder have recently been localized to a gene (WRN) encoding a protein that possesses DNA helicase and exonuclease activities. Patients carrying WRN gene mutations exhibit an elevated rate of cancer, accompanied by increased genomic instability. The latter features are also characteristic of the loss of function of p53, a tumor suppressor that is very frequently inactivated in human cancer. Moreover, changes in the activity of p53 have been implicated in the onset of cellular replicative senescence. We report here that the WRN protein can form a specific physical interaction with p53. This interaction involves the carboxyl-terminal part of WRN and the extreme carboxyl terminus of p53, a region that plays an important role in regulating the functional state of p53. A small fraction of WRN can be found in complex with endogenous p53 in nontransfected cells. Overexpression of WRN leads to augmented p53-dependent transcriptional activity and induction of p21(Waf1) protein expression. These findings support the existence of a cross-talk between WRN and p53, which may be important for maintaining genomic integrity and for preventing the accumulation of aberrations that can give rise to premature senescence and cancer.
引用
收藏
页码:29463 / 29469
页数:7
相关论文
共 68 条
[21]   The Werner syndrome protein is a DNA helicase [J].
Gray, MD ;
Shen, JC ;
KamathLoeb, AS ;
Blank, A ;
Sopher, BL ;
Martin, GM ;
Oshima, J ;
Loeb, LA .
NATURE GENETICS, 1997, 17 (01) :100-103
[22]   p53; From inductive signal to cellular effect [J].
Hansen, R ;
Oren, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (01) :46-51
[23]   COOPERATIVE EFFECT OF ANTISENSE-RB AND ANTISENSE-P53 OLIGOMERS ON THE EXTENSION OF LIFE-SPAN IN HUMAN-DIPLOID FIBROBLASTS, TIG-1 [J].
HARA, E ;
TSURUI, H ;
SHINOZAKI, A ;
NAKADA, S ;
ODA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (01) :528-534
[24]   MONOCLONAL-ANTIBODIES SPECIFIC FOR SIMIAN VIRUS-40 TUMOR-ANTIGENS [J].
HARLOW, E ;
CRAWFORD, LV ;
PIM, DC ;
WILLIAMSON, NM .
JOURNAL OF VIROLOGY, 1981, 39 (03) :861-869
[25]   P53 ALTERATION IS A COMMON EVENT IN THE SPONTANEOUS IMMORTALIZATION OF PRIMARY BALB/C MURINE EMBRYO FIBROBLASTS [J].
HARVEY, DM ;
LEVINE, AJ .
GENES & DEVELOPMENT, 1991, 5 (12B) :2375-2385
[26]  
Hollstein M, 1997, Recent Results Cancer Res, V143, P369
[27]   2 DOMAINS OF P53 INTERACT WITH THE TATA-BINDING PROTEIN, AND THE ADENOVIRUS-13S E1A-PROTEIN DISRUPTS THE ASSOCIATION, RELIEVING P53-MEDIATED TRANSCRIPTIONAL REPRESSION [J].
HORIKOSHI, N ;
USHEVA, A ;
CHEN, JD ;
LEVINE, AJ ;
WEINMANN, R ;
SHENK, T .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :227-234
[28]   The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease [J].
Huang, SR ;
Li, BM ;
Gray, MD ;
Oshima, J ;
Mian, SI ;
Campisi, J .
NATURE GENETICS, 1998, 20 (02) :114-116
[29]   ALLOSTERIC ACTIVATION OF LATENT P53 TETRAMERS [J].
HUPP, TR ;
LANE, DP .
CURRENT BIOLOGY, 1994, 4 (10) :865-875
[30]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886